2015 Agenda

 

November 10th, 2015

Heldrich Hotel, New Brunswick, NJ 08901

 

 

 

8:00 - 8:30 A.M.

REGISTRATION AND COFFEE

8:30 - 9:00 A.M.

Welcome
Dr. Bozena "Bo" Michniak-Kohn, Director CDR, and Professor, Rutgers School of Pharmacy, Dr. William Ju, President, Advancing Innovation in Dermatology, Inc., Dr. Chris Molloy, Senior Vice President for Research and Economic Development, Rutgers and Dr. Tamara Minko, Chair, Rutgers School of Pharmacy and

9:00 - 9:30 A.M.

Miri Seiberg, Ph.D., Seiberg Consulting "Itch - An Overview"

9:30 - 10:00 A.M.

Ethan Lerner MD, Associate Professor of Dermatology at Harvard Medical School and the Massachusetts General Hospital "Targeting Itch: Are We There Yet?"

10:00 - 10:05 A.M.

Bo Michniak-Kohn, Ph.D., CDR Sponsor of the Year Award

10:05 - 10:30 P.M.

COFFEE BREAK, POSTER SESSION AND NETWORKING 

10:30 - 11:10 P.M.

Gil Yosipovitch, MD, Professor and Chair of the Department of Dermatology at Temple University School of Medicine "Itch: More Than Scratching the Surface"

11:10 - 11:40 P.M.

Kathy Albers, Ph.D., Professor of  Neurobiology at the University of Pittsburgh. "Keratinocytes and Activation of Pain Fiber Signaling"

12:40 - 12:10 P.M.

Ellen Lumpkin, Ph.D., Associate Professor  Biology (in Dermatology) and of Physiology and Cellular Biophysics "Illuminating Mechanisms of Mammalian Touch"

12:10 - 12:40 P.M.

David Owens, Ph.D., J. Lowry Miller Associate Professor of Dermatology and Pathology and Cell Biology "The Touch Dome Stem Cell Niche"

12:40 - 2:40 P.M.

LUNCH AND NETWORKING

2:40 - 3:10 P.M.

Lee T. Zane, MD, Senior Vice Preseident and Chief Medical Officer at Anacor Pharmaceuticals "Discovery and Development of Topical PDE-4 Inhibitor for the Potential Treatment of Atopic Dermatitis"

3:10 - 3:25 P.M.

Didier Leclercq, Galderma “Skin Health Investigation, Education and Longevity Development (SHIELD)

3:25 - 3:45 P.M.

COFFEE BREAK, POSTER SESSION AND NETWORKING

3:45 - 4:15 pm

Tina Garyantes Ph.D., Vice President of Innovation at Chromocell "Learning from a Novel, Selective naV1.7 Inhibitor for the Systemic Inhibition of Pain and Touch"

4:15 - 4:45 P.M.

Gareth Winckle, Ph.D., Formulation Unit Manager for Galderma "Sensorial Aspects of Topical Formulation: Art & Science"

4:45 P.M.

Closing Remarks